Novavax (NVAX) Other Non Operating Income: 2010-2025
Historic Other Non Operating Income for Novavax (NVAX) over the last 13 years, with Sep 2025 value amounting to -$28.7 million.
- Novavax's Other Non Operating Income fell 280.34% to -$28.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 83.34%. This contributed to the annual value of $40.4 million for FY2024, which is 6.72% up from last year.
- Latest data reveals that Novavax reported Other Non Operating Income of -$28.7 million as of Q3 2025, which was down 341.25% from $11.9 million recorded in Q2 2025.
- Over the past 5 years, Novavax's Other Non Operating Income peaked at $64.0 million during Q4 2022, and registered a low of -$34.8 million during Q3 2022.
- Moreover, its 3-year median value for Other Non Operating Income was $10.1 million (2025), whereas its average is $6.5 million.
- The largest annual percentage gain for Novavax's Other Non Operating Income in the last 5 years was 14,639.86% (2022), contrasted with its biggest fall of 756.31% (2022).
- Quarterly analysis of 5 years shows Novavax's Other Non Operating Income stood at $434,000 in 2021, then surged by 14,639.86% to $64.0 million in 2022, then crashed by 82.83% to $11.0 million in 2023, then climbed by 19.58% to $13.1 million in 2024, then plummeted by 280.34% to -$28.7 million in 2025.
- Its Other Non Operating Income was -$28.7 million in Q3 2025, compared to $11.9 million in Q2 2025 and $10.1 million in Q1 2025.